ENVB - צמיחת הכנסות ב-12 חודשים נגררים Enveric Biosciences

Leveraging the scientific potential of its team of PhD chemists, Enveric Biosciences (ENVB) shows a YoY sales volume growth trajectory over a rolling period where the value of 0.00 expresses the metric level. Development is based on neuroplastogens and the success of EB-003, while the strategy focuses on optimizing the patent portfolio and creating new psilocybin molecules for psychiatry.
Enveric Biosciences, Inc. - פילוחים אנליטיים ומדדי מפתח (ENVB)

Investors assess the margin of safety through the dynamics of total revenue over the last 12 months, where the percentage deviation from the previous year reveals the business model's resilience to cyclical fluctuations. The integration of ESG standards into the development of psychoactive molecules by Enveric Biosciences (ENVB) is reflected in the 12-month YoY sales change chart, allowing for a correlation between the scaling pace of bioethical research and the fundamental value of this high-risk biotech asset.